4//SEC Filing
Trius Therapeutics Inc 4
Accession 0001209191-13-036534
CIK 0001356857operating
Filed
Jul 11, 8:00 PM ET
Accepted
Jul 12, 6:57 PM ET
Size
8.8 KB
Accession
0001209191-13-036534
Insider Transaction Report
Form 4
Finn John
Chief Scientific Officer
Transactions
- Sale
Common Stock
2013-07-10$8.58/sh−1,000$8,580→ 176,860 total(indirect: By Trust) - Sale
Common Stock
2013-07-12$10.10/sh−5,000$50,500→ 171,360 total(indirect: By Trust) - Sale
Common Stock
2013-07-11$9.32/sh−500$4,660→ 176,360 total(indirect: By Trust)
Holdings
- 2,151
Common Stock
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2012
Documents
Issuer
Trius Therapeutics Inc
CIK 0001356857
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001356857
Filing Metadata
- Form type
- 4
- Filed
- Jul 11, 8:00 PM ET
- Accepted
- Jul 12, 6:57 PM ET
- Size
- 8.8 KB